Fulgent Genetics President/COO Jian Xie Sells 4,361 Shares for Tax Withholding

This Form 4 filing reports that Jian Xie, President and COO of Fulgent Genetics, Inc., sold 4,361 shares of common stock on April 26, 2026, at a price of $16.31 per share, resulting in total proceeds of approximately $71,128. The transaction was coded as "F" (tax withholding obligation) and involved shares withheld to satisfy tax obligations arising from the vesting of restricted stock units. These RSUs were originally reported in November 2022 and were assumed pursuant to a merger agreement. Following the transaction, Xie directly holds 370,952 shares. Additionally, Xie indirectly holds 220,816 shares through The Hsieh Family Dynasty Trust, where he serves on the investment committee, though he disclaims beneficial interest except for any pecuniary interest. The filing was signed by Paul Kim as attorney-in-fact on April 28, 2026.